Rm. Feakins et al., Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast, HUMAN PATH, 31(10), 2000, pp. 1214-1222
Citations number
35
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
The development of normal breast tissue and the pathogenesis of various tum
ors are influenced by growth factor-mediated epithelial-stromal interaction
s. Similar interactions may occur in fibroepithelial breast tumors. We have
studied the expression of platelet-derived growth factor (PDGF) and PDGF b
eta receptor (PDGFR beta) in 46 phyllodes tumors (18 benign, 15 borderline,
13 malignant), 11 fibroadenomas, and 6 samples of normal breast. There was
neoplastic stromal cell positivity for PDGFR beta in almost 50% of phyllod
es tumors and for PDGF in 24%. Both were associated with prominent nuclear
pleomorphism (P < .01), PDGF with high grade (P < .01), and a higher mean K
i-67 labeling index (P = .013), and PDGFR beta with conspicuous stromal ove
rgrowth (P < .01). Go-positivity for stromal PDGF and PDGFR<beta> was found
in 15% of phyllodes tumors, and for epithelial PDGF and stromal PDGFR beta
in 43%. Both types of co-positivity were associated with prominent nuclear
pleomorphism and the latter type with conspicuous stromal overgrowth (all
P < .01). Follow-up of 41 phyllodes tumors showed that disease-related deat
h was associated with established histologic features of malignancy includi
ng mitotic count, stromal overgrowth, an infiltrative tumor margin, and nuc
lear pleomorphism. In addition, stromal PDGFR<beta> positivity (P = .013) a
nd epithelial PDGF/stromal PDGFR beta co-positivity (P = .0075) were associ
ated with disease-related death. Stromal PDGF and PDGFR beta expression in
fibroadenomas was less common and less extensive (P < .05) than in phyllode
s tumors. The results suggest that PDGF influences the pathogenesis of fibr
oepithelial breast tumors and that PDGF-dependent paracrine and autocrine m
echanisms may operate. Also, it is possible that assessment of PDGF and PDG
FR<beta> expression could contribute to the management of these tumors in t
he future. HUM PATHOL 31:1214-1222. Copyright (C) 2000 by W.B. Saunders Com
pany.